By examining peripheral blood lymphocytes from a patient with BRAF V600E+ melanoma who had a clinical response after TIL therapy, Veatch et al. identified a CD4+ T cell clone specific for an HLA-DQB1*03-restricted epitope of BRAF V600E (71). This evidence concerns the gene BRAF and melanoma.